RainMed Medical Inc.

Home
China
Suzhou
RainMed Medical Inc.

The corporate self-developed Coronary angiography fractional flow reserve analysis system, abbreviat

Founded in 2014, RainMed Medical is committed to becoming the world's leading panvascular interventional robotics company. Currently, it focusing on the design, development and commercialization of coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microcirculatory resistance (caIMR) systems. With independent innovation and great efforts,

RainMed Medical has gradually built up a global R&D, production, sales and service network. RainMed Medical has actively cooperated with top medical centers and experts at home and abroad to build a perfect patent system. Many research results are continuously published in authoritative journals such as “Cardiovascular Research” and “JACC: Cardiovascular Interventions”. In addition, the company has signed strategic cooperation agreements with many top medical device distribution service platforms in China, developed a strict quality inspection system and perfect supply process, and successfully passed the medical device quality management system certification.

19/10/2023

Huihui Wu, Deputy Director of Suzhou Industrial Park Administrative Committee, Visited RainMed Medical to Provide More Support for the Development of High-tech Medical Enterprises.

Recently, Huihui Wu, member of the Party Working Committee and Deputy Director of the Suzhou Industrial Park Administrative Committee, visited RainMed Medical to investigate how the company operated and discuss the latest policies to help address its pain points and difficulties in the development process. He was accompanied by Kangjian Liu, Vice President and Secretary of the Board of RainMed Medical and Liu gave a comprehensive introduction to the company's development, strategic layout, and product pipeline.

Deputy Director Huihui Wu spoke highly of RainMed's achievements in medical innovation. He stated that RainMed Medical is one of the leading local medical device enterprises in independent innovation, and the government will strongly support RainMed's development to help it grow into a towering tree.

Read the full press release here: https://en.rainmed.com/news/206.html

13/10/2023

Xinhua Net Interview | Mr. Kangjian Liu: Precision Diagnosis and Treatment Services for Public Health. Lean Management Enhances Enterprise Efficiency

Recently, RainMed Medical was invited by Xinhua Net to participate in the Entrepreneur Annual Conference Interview. Mr. Kangjian Liu, Vice President and Secretary of the Board of Directors of the company, represented RainMed for the interview. As one of the leaders in the field of vascular intervention surgical robots in China, RainMed Medical has innovatively developed and launched a series of pioneering vascular functional diagnostic products. Through lean management, the company has greatly improved its production and work efficiency, and has received dual recognition from the market and capital, becoming an emerging force driving the development of domestic private enterprises. In the interview, the host from Xinhua Net engages in an in-depth discussion with Mr. Kangjian Liu on hot topics such as digital transformation, entrepreneurial spirit, and the development of the private economy.

.

Read the full press release here: https://en.rainmed.com/news/205.html

29/09/2023

Healthy hearts, happy lives. Join RainMed on World Heart Day to promote heart wellness for all population!

28/09/2023

RainMed Medical Successfully Held the Launch Meeting of WMS Intelligent Warehousing Project to Further Optimized Its Customer Service Level

Recently, RainMed WMS Intelligent Warehousing Project launch meeting was successfully held, with ZHECN Intelligent Manufacturing in attendance. During the meeting, the main project members from both sides had an in-depth discussion on the implementation of the project. The WMS Intelligent Warehousing project aims to establish intelligent warehousing and enhance the competitiveness of the company's industrial supply chain. Through comprehensive application of material barcode full-process traceability management, refined management of storage locations, and visualized inventory management, the project aims to achieve anti-delay and anti-error effects, further improving the intelligent warehousing management level of RainMed Medical.

With the rapid development of information technology and internet, digitalization has become an important driving force for the development of the medical device industry. According to relevant data, the global digital medical market size was $211 billion in 2022, and is expected to grow at a compound annual growth rate of 18.6% from 2023 to 2030, reaching $809.2 billion. Global medical digital transformation has become a major trend. As a listed company in the field of vascular intervention surgery robots, RainMed Medical values "innovation" and "breakthroughs". Facing the trend of digitalization, it is committed to building precision manufacturing workshops and digital management systems, providing customers with more efficient and convenient service experience.

-delay -error

Read the full press release here: https://en.rainmed.com/news/204.html

22/09/2023

RainMed Medical and Dushu Lake Hospital Affiliated to Soochow University Have Signed a Strategic Cooperation Agreement to Promote High-quality Hospital-enterprise Cooperation.

In order to improve the mechanism of technology transfer, the National Center of Technology Innovation for Biopharmaceuticals and BioBAY recently jointly organized the Biopharmaceutical "Industry-University-Research-Hospital" integration development forum, and launched the clinical cooperation ceremony. At the ceremony, five authoritative medical institutions and leading innovative medical enterprises in Suzhou signed a strategic cooperation framework agreement. As one of the representative enterprises of hospital-enterprise cooperation in Suzhou Industrial Park, RainMed Medical was invited to participate in the launch ceremony. Mr. Kangjian Liu, Vice President and Secretary of the Board of RainMed Medical, represented the company to sign the strategic cooperation agreement with Professor Yafeng Zhou, Vice President of Dushu Lake Hospital Affiliated to Soochow University, a key comprehensive hospital in Suzhou.

Clinical research has always been an indispensable key factor in the medical progress of innovation industry in China. In order to solve the pain points of the clinical resource docking needs of biopharmaceutical enterprises, support the integration and innovative development of health and biopharmaceutical industries, and create a new situation of high-quality development of hospital-enterprise cooperation, Suzhou has successively introduced relevant policies and established the Suzhou Clinical Research Service Platform to support clinical resources for research and development and industrial development services, promote the coordinated development of basic medical research and clinical treatment, accelerate the clinical transformation of new diagnostic and therapeutic technologies, and improve the research and development speed of biopharmaceutical enterprises. This signing cooperation will help RainMed Medical better focus on clinical research, develop more innovative diagnostic and therapeutic products with clinical value and practicality.

Read the full press release here: https://en.rainmed.com/news/203.html

21/09/2023

On this International Day of Peace, let's unite and work towards a world where everyone can live in peace and harmony.

15/09/2023

Good News! "Analysis and Assessment System of Fractional Flow Reserve Based on Coronary Angiography" Project From Professor Jianping Li's Team Has Been Awarded One of the Top Ten Achievements of the "CHDR Project" from 2012 to 2022.

Recently, the Beijing Municipal Health Commission announced the top ten achievements of the "Capital Health Development Research Project" (abbreviated as "CHDR Project") from 2012 to 2022 at the Public Health Summit Forum of the China International Fair for Trade in Services 2023. After multiple rounds of assessment, the "Analysis and Assessment System of Fractional Flow Reserve Based on Coronary Angiography" project, led by Professor Jianping Li from Peking University First Hospital, stood out and was awarded one of the top ten achievements of the "CHDR Project." It was showcased on the world's only national-level international comprehensive service trade platform. The research technology of the "Analysis and Assessment System of Fractional Flow Reserve Based on Coronary Angiography" project is from caFFR system domestically developed by RainMed Medical, which can accurately measure coronary blood flow without pressure wires and hyperemic agents, and assist operators in achieving precise diagnosis and treatment of coronary artery disease.

The "CHDR Project" was established in 2011 and is a project under the jurisdiction of the Beijing Municipal Health Commission aimed at promoting sustainable and coordinated development of the capital's medical and health industry, comprehensively improving medical and health service capabilities, and improving disease prevention and treatment levels. To systematically evaluate and summarize the research results and experience of the "CHDR Project" over the past 10 years, the Beijing Municipal Health Commission launched a 10-year achievement investigation, delving into representative projects in terms of achievement transformation, paper publication, and award-winning. After a rigorous selection process, the "Analysis and Assessment System of Fractional Flow Reserve Based on Angiography" project led by Professor Jianping Li's team from Peking University First Hospital was successfully selected. This recognition demonstrates the leading and exemplary role of RainMed Medical's caFFR system in the precise diagnosis of coronary artery disease and its clinical promotion, which has gained high recognition from government departments, experts and scholars.

Read the full press release here: https://en.rainmed.com/news/202.html

08/09/2023

Chairman Yaping Li and His Delegation from the Standing Committee of Suzhou Municipal People's Congress Visited RainMed Medical, Fully Affirming the Domestic Independent Innovation in Medical Technology.

On September 7th, Yaping Li, Chairman of the Standing Committee of Suzhou Municipal People's Congress, Xianghua Wen, Vice Chairman of the Standing Committee of Suzhou Municipal People's Congress, and Qiao Zhang, Deputy Mayor of Suzhou, visited RainMed Medical to inspect the progress of the implementation of the proposal "Promoting the Deep Integration of Innovation Chain, Industry Chain, Capital Chain and Talent Chain, and Creating the Optimal Industrial Innovation Ecology".

During the visit, Mr. Yunfei Huo, Chairman of the Board, Executive Director and CEO of RainMed Medical introduced the company's development history, talent team, academic achievements, product matrix, production capacity, and marketing to the leaders. He also demonstrated the operation of cutting-edge vascular disease diagnosis and treatment products such as the caFFR system, caIMR system, and shockwave balloon. Chairman Yaping Li highly praised RainMed Medical's comprehensive strength and fully affirmed its leadership and demonstration role in implementing the "Four Chains" proposal. He encouraged high-tech enterprises led by RainMed Medical to continue to maintain scientific research innovation, play a leading role in driving the innovation chain, and provide strong impetus for deepening the reform of "Four Chains" integration.

Read the full press release here: https://lnkd.in/gn5PGyzy

25/08/2023

2023 Papers | With Continuous Breakthroughs in Microcirculation Diagnosis and Research Innovation, RainMed Medical's caIMR Unlocks More Clinical Applications (2)

From the proposal of the technology to its application, the caIMR system has continuously attracted the attention and research of top experts and scholars at home and abroad, and has continuously unlocked the potential clinical value of itself, providing a convenient and practical clinical indicator for the evaluation of high-risk pathogenic factors of coronary heart disease and the diagnosis of complex coronary artery diseases. Currently, with the increasing popularity of caIMR research, and abundant research results are continuously included in internationally renowned high-level SCI journals, laying a solid theoretical foundation for the large-scale application of caIMR. The following are the academic achievements of the caIMR system since the beginning of 2023, which involve the demonstration of the diagnostic performance of caIMR and the prediction and assessment of common types of diseases such as stable angina pectoris, acute myocardial infarction, dilated cardiomyopathy, and preserved ejection fraction heart failure. It is hoped that new ideas and diagnostic methods for clinical diagnosis and treatment of vascular diseases can be provided.

(DCM) (CMD)

Read the full press release here: https://en.rainmed.com/news/199.html

18/08/2023

2023 Papers | With Continuous Breakthroughs in Microcirculation Diagnosis and Research Innovation, RainMed Medical's caIMR Unlocks More Clinical Applications (1)

Precision diagnostics is the premise of scientific treatment. Microcirculation plays a crucial role in the supply and regulation of myocardial blood flow. It is a potential inducer and independent predictor of various types of coronary heart disease. The traditional method of microcirculation assessment has various limitations, which makes it impossible to be widely used in clinical practice. As one of the optimal ways to achieve precise diagnosis and treatment of vascular diseases, the diagnosis of coronary microcirculation dysfunctions has been clinically ignored due to the difficulty in assessment. To address this issue, RainMed Medical has pioneered the world's first non-invasive coronary microcirculation diagnosis system, caIMR, which has expanded non-invasive microcirculation diagnosis technology and brings new opportunities for the diagnosis and treatment of complex cardiovascular diseases in clinical practice.

From the proposal of the technology to its application, the caIMR system has continuously attracted the attention and research of top experts and scholars at home and abroad, and has continuously unlocked the potential clinical value of itself, providing a convenient and practical clinical indicator for the evaluation of high-risk pathogenic factors of coronary heart disease and the diagnosis of complex coronary artery diseases. The following are the academic achievements of the caIMR system since the beginning of 2023, which involve the demonstration of the diagnostic performance of caIMR and the prediction and assessment of common types of diseases such as stable angina pectoris, acute myocardial infarction, dilated cardiomyopathy, and preserved ejection fraction heart failure. It is hoped that new ideas and diagnostic methods for clinical diagnosis and treatment of vascular diseases can be provided.

Read the full press release here: http://en.rainmed.com/news/198.html

11/08/2023

Secretary of the Foshan Municipal Party Committee Ke Zheng Led a Delegation of Government Officials on a Visit to RainMed Medical to Feel the Robust Development of the Medical Industry.

Recently, Vice Chairman of the Guangdong Provincial Committee of the Chinese People's Political Consultative Conference and Secretary of the Foshan Municipal Party Committee Ke Zheng led a delegation of government officials on a visit to RainMed Medical to investigate the local development of the medical industry. Professor Yunlong Huo, one of the founding shareholders of RainMed Medical, Vice President and Secretary of the Board of RainMed Medical Kangjian Liu, and Vice President of RainMed Medical Yang Gu accompanied the delegation and gave detailed introductions on RainMed’s development, strategic planning, and innovative product systems. Secretary Zheng recognized the innovation of RainMed Medical's products and praised the company as a leading medical device enterprise that has played a significant role in the local economic and industrial development of Suzhou.

Read the full press release here: http://en.rainmed.com/news/197.html

04/08/2023

The Expert Team of Beijing Anzhen Hospital Further Confirmed That RainMed Medical’s caIMR System Can Immediately Recognize and Predict the Occurrence and Evolution of Microvascular Injury in Patients After PPCI.

Recently, Professor Shaoping Nie and Professor Xiao Wang from Beijing Anzhen Hospital, Capital Medical University, published a cutting-edge research article titled "Coronary angiography-derived index of microcirculatory resistance and evolution of infarct pathology after ST-segment-elevation myocardial infarction" in a top-tier journal. The study revealed the immediate diagnostic and long-term predictive value of the caIMR system for microvascular injury after primary percutaneous coronary intervention (PPCI). Microvascular obstruction (MVO) is an upstream problem and is potentially reversible, but severe microvascular injury progresses to irreversible intramyocardial haemorrhage (IMH). IMH drives infarct expansion after reperfusion and compromises myocardial salvage. This study confirmed that caIMR can objectively reflect the degree and evolution of postoperative infarct pathology in acute myocardial infarction patients, provide a risk stratification index for microcirculation injury diagnosis and treatment, and maximize clinical benefits for patients.

Read the full press release here: http://en.rainmed.com/news/196.html

28/07/2023

Award | RainMed Medical Was Awarded the “Pioneering Enterprise of Independent Innovation” and "Law-abiding and Honest Enterprise" in the "2022-2023 China Medical Industry Most Influential List".

Recently, the All-China Federation of Industry and Commerce announced the "2022-2023 China Medical Industry Most Influential List" at the China Medical Industry Development Forum. After a two-month evaluation process, RainMed Medical stood out among more than 1,000 participating companies and was awarded the “Pioneering Enterprise of Independent Innovation” and "Law-abiding and Honest Enterprise" honors along with leading companies in the industry such as HENGRUI, United Imaging Healthcare, and LEPU.

The China Medical Industry Development Forum is an authoritative brand event in China's medical industry. The event aims to promote industry development and invites top domestic expert teams to conduct comprehensive evaluations of enterprises in terms of research and development, production, service, reputation, and other aspects. This award indicates that the expert team widely recognizes RainMed Medical's strong comprehensive strength in its software and hardware, outstanding scientific research and innovation level, and profound clinical application value. It is believed that the large-scale clinical application of RainMed Medical's series of innovative products will promote the rapid development of precision medicine for vascular diseases in China.

Read the full press release here: http://en.rainmed.com/news/195.html

21/07/2023

RainMed Medical Was Invited to Attend 2023 China Medical Device Intellectual Property Development Summit Forum to Promote the Development and Cooperation of Medical Device Intellectual Property Rights with Top 100 Medical Device Companies From Home and Abroad

The intellectual property system is a powerful driving force for economic and social development. In July 2023, the China Medical Device Intellectual Property Development Summit Forum and Beijing International Life and Health Industry Expo were successfully held at Beijing China International Convention and Exhibition Center (Jing’an Zhuang) in Beijing. With the theme of "Gathering of Intellectual Property Rights and Co-protection of Innovation", RainMed Medical was invited to share and exchange its intellectual property layout systems with property experts and decision-makers from domestic and foreign top 100 medical device companies to promote the development and cooperation of China's medical device intellectual property rights and protect the innovative achievements of medical devices, as well as promote new opportunities for industry-academic-research-clinical cooperation.

At the summit, Miss. Nina Cheng, the International Marketing Manager of RainMed Medical, delivered a speech sharing the intellectual property management system and experience of RainMed Medical. RainMed Medical is an innovative enterprise that values the cultivation of high-end talents and product research and innovation. After eight years of intensive research, the company has launched a series of functional diagnostic products with outstanding clinical application value, promoting the rapid development of precision medicine in China and being selected as a "national high-tech enterprise". As of now, RainMed Medical has applied for nearly 300 domestic and foreign patents, including invention, utility model, and design patents. Among them, 36 PCT patents are still under protection, which have established a solid technical barrier in the industry. Currently, It has been awarded th e title of "Advanced Enterprise in Intellectual Property Work" for four consecutive years and has won the "Intellectual Property Financial Innovation Award".In the future, RainMed Medical will continue to lead by example, actively respond to national policies, play a leading role as an advanced enterprise in intellectual property work, promote the establishment of a sound mechanism for protecting trade secrets, promote greater innovation vitality for enterprises, and create a fair competitive market order!

Read the full press release here: http://en.rainmed.com/news/194.html

10/07/2023

RainMed Medical's Coronary Functional Assessment Product caFFR System Has Attracted Widespread Attention at 2023 CITIC MX Exhibition and Was Invited to Explain Its Working Principles to Clinicians at Hospitals in Mexico.

At the end of June 2023, RainMed Medical showcased its independently developed coronary functional assessment product caFFR system at the 2023 CITIC MX exhibition. It not only has advantages such as high accuracy, sensitivity, and specificity, but also has advanced user experience and design, which can help doctors with better treatment of coronary artery disease. After the exhibition, RainMed Medical was invited to explain the working principles and operating procedures of caFFR to clinicians. As an innovative functional diagnostic system, the accurate diagnostic value of caFFR has been highly recognized by Mexican clinicians.

As a company dedicated to the research and production of high-quality medical devices, RainMed Medical has been committed to providing advanced treatment solutions for global patients. The company has now launched a global sales plan and it is believed that caFFR system will soon be available and sold in the North American market. In the future, RainMed Medical will continue to expand its market and provide more accurate coronary functional diagnostic solutions for global patients.

06/07/2023

We are Honored to Showcase Our (caFFR) Technology and the Strategic Partnership Solution with SINOMED at the 2023 CITIC MX Exhibition in Mexico!

The caFFR system complies with international standards and has obtained CE, TGA, and NMPA certificates. We are currently applying for FDA certificate. The participation at 2023 CITIC MX is a valuable experience for our company. We introduced caFFR's features and advantages to a larger population, exchanged technical innovations within the industry, and let more people know about the brand of RainMed Medical.

At the symposium jointly held with SINOMED on June 29th, we introduced the strategic cooperation concept of “Redefine PCI”. This concept includes SINOMED's Healing Targeted (HT Supreme) drug eluting stent and RainMed Medical's caFFR system, aiming to improve PCI procedure efficiency and optimize daily practice.

Overall, the exhibition was a complete success, and we look forward to the next event!

30/06/2023

Award | RainMed Medical's caIMR System was Awarded the "Gold Wish Award · Optimal Solution for Operating Room Efficiency" by CN-Healthcare

Recently, after a two-month review process, the second "Gold Wish Award" optimal solution rank, hosted by CN-Healthcare, was released at the 5th China Medical Innovation Summit. After strict screening by 50 authoritative experts, RainMed Medical's caIMR system emerged among nearly 100 operating room solutions and was awarded the optimal solution for operating rooms along with other high-quality companies in the industry such as MicroPort and InferVersion. The judging experts stated that RainMed Medical's caIMR system can solve the problems of guidewire-derived IMR assessment technology, improve the clinical diagnosis level of coronary microcirculation function, and has solid theoretical foundation and strong operability, making it an optimal solution for improving operating room efficiency.

Read the full press release here: http://en.rainmed.com/news/193.html

26/06/2023

Come and join us to learn more about a new solution , where SINOMED's (HT Supreme) drug eluting stent and RainMed Medical Inc.'s (caFFR) technology will be combined to bring a more accurate treatment to daily practice.

The symposium will be held on June 29 at the upcoming CITIC MX 2023 and the fundamentals of both products will be clearly introduced. We warmly welcome attendees who are interested in learning more about our latest products and services!

Address

NE-31, Northeast District Of Nano City, Jiangsu, P. R.
Suzhou

Website

http://2108285030.pool203-site.make.yun300.cn/

Alerts

Be the first to know and let us send you an email when RainMed Medical Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to RainMed Medical Inc.: